Kidney drug combo under microscope: can they keep fluids in check?
NCT ID NCT05884866
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 2 study investigated how the drugs dapagliflozin and balcinrenone, alone or together, affect the body's handling of water and salts in people over 50 with stage 3 chronic kidney disease. Over 28 days, 103 participants took daily pills to measure changes in urine and blood. The goal was to understand the drugs' mechanisms, not to test a cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dapagliflozin and balcinrenone
- What this could lead to
- If successful, this study could clarify how these drugs work together to manage fluid and salt balance in chronic kidney disease, potentially improving treatment strategies.
- What could go wrong
- This is a small, early-phase mechanistic study with only 103 participants over 28 days. It is designed to understand how the drugs work, not to prove they are effective treatments. Results may not lead to direct patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 3 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assistance Publique-Hopitaux de Marseille (AP-HM)
Marseille, 13005, France
-
Klinikum Nuernberg
Nuremberg, Bavaria, 90419, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could predict who faces rapid kidney decline in diabetes
- Zapping kidney nerves: a new hope for stubborn high blood pressure?
- Thousands of kidney patients tracked to unlock better disease management
- New study: can a smart glucose monitor help diabetics with kidney problems?
- Study aims to see if patient diaries match insurance data
- Can a cheap arthritis drug shield kidneys from heart and bone damage?